Treatment of Giardiasis
- PMID:15625030
- DOI: 10.1007/s11938-005-0047-3
Treatment of Giardiasis
Abstract
Tinidazole is the first-line drug treatment of giardiasis, as it requires only a single dose to cure infection in most individuals. The related drug metronidazole is as effective, but it requires 5 to 7 days of three times a day therapy. Nitazoxanide appears in limited studies to be as effective as tinidazole or metronidazole, and it does not have the bitter taste of nitroimidazoles. A good alternate for use during pregnancy is paromomycin. Cure of infection varies between 60% and 100% with one course of treatment. Less effective and/or less well-tolerated drugs for the treatment of giardiasis include albendazole, quinacrine, and furazolidone; the use of these agents should be reserved for giardiasis refractory to treatment with the first-line agents.
Similar articles
- Treatment of giardiasis.Gardner TB, Hill DR.Gardner TB, et al.Clin Microbiol Rev. 2001 Jan;14(1):114-28. doi: 10.1128/CMR.14.1.114-128.2001.Clin Microbiol Rev. 2001.PMID:11148005Free PMC article.Review.
- Treatment of giardiasis in children with quinacrine, metronidazole, tinidazole and ornidazole.Sabchareon A, Chongsuphajaisiddhi T, Attanath P.Sabchareon A, et al.Southeast Asian J Trop Med Public Health. 1980 Jun;11(2):280-4.Southeast Asian J Trop Med Public Health. 1980.PMID:7434079Clinical Trial.
- Treatment strategies for nitroimidazole-refractory giardiasis: a systematic review.Bourque DL, Neumayr A, Libman M, Chen LH.Bourque DL, et al.J Travel Med. 2022 Jan 17;29(1):taab120. doi: 10.1093/jtm/taab120.J Travel Med. 2022.PMID:34350966
- Treatment-ladder and genetic characterisation of parasites in refractory giardiasis after an outbreak in Norway.Mørch K, Hanevik K, Robertson LJ, Strand EA, Langeland N.Mørch K, et al.J Infect. 2008 Apr;56(4):268-73. doi: 10.1016/j.jinf.2008.01.013. Epub 2008 Mar 7.J Infect. 2008.PMID:18328567
- Treatment of giardiasis: literature review and recommendations.Lerman SJ, Walker RA.Lerman SJ, et al.Clin Pediatr (Phila). 1982 Jul;21(7):409-14. doi: 10.1177/000992288202100704.Clin Pediatr (Phila). 1982.PMID:7044642Review.
Cited by
- Terminal restriction fragment length polymorphism for identification of Cryptosporidium species in human feces.Waldron LS, Ferrari BC, Gillings MR, Power ML.Waldron LS, et al.Appl Environ Microbiol. 2009 Jan;75(1):108-12. doi: 10.1128/AEM.01341-08. Epub 2008 Oct 31.Appl Environ Microbiol. 2009.PMID:18978074Free PMC article.
- Treatment of giardiasis in common marmosets (Callithrix jacchus) with tinidazole.Kramer JA, Hachey AM, Wachtman LM, Mansfield KG.Kramer JA, et al.Comp Med. 2009 Apr;59(2):174-9.Comp Med. 2009.PMID:19389310Free PMC article.
- Bile-Salt-Hydrolases from the Probiotic StrainLactobacillus johnsonii La1 Mediate Anti-giardial Activityin Vitro andin Vivo.Allain T, Chaouch S, Thomas M, Vallée I, Buret AG, Langella P, Grellier P, Polack B, Bermúdez-Humarán LG, Florent I.Allain T, et al.Front Microbiol. 2018 Jan 31;8:2707. doi: 10.3389/fmicb.2017.02707. eCollection 2017.Front Microbiol. 2018.PMID:29472895Free PMC article.
- Survey of obstetrician-gynecologists about giardiasis.Krueger A, Schulkin J, L Jones J.Krueger A, et al.Infect Dis Obstet Gynecol. 2007;2007:21261. doi: 10.1155/2007/21261.Infect Dis Obstet Gynecol. 2007.PMID:17710238Free PMC article.
- Structural and functional perturbation of Giardia lamblia triosephosphate isomerase by modification of a non-catalytic, non-conserved region.Hernández-Alcántara G, Torres-Larios A, Enríquez-Flores S, García-Torres I, Castillo-Villanueva A, Méndez ST, de la Mora-de la Mora I, Gómez-Manzo S, Torres-Arroyo A, López-Velázquez G, Reyes-Vivas H, Oria-Hernández J.Hernández-Alcántara G, et al.PLoS One. 2013 Jul 22;8(7):e69031. doi: 10.1371/journal.pone.0069031. Print 2013.PLoS One. 2013.PMID:23894402Free PMC article.
References
Related information
Grants and funding
LinkOut - more resources
Full Text Sources